Wolverine Trading, LLC United Therapeutics Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $611,204 - $723,579	2,900 New	2,900 $666,000
Q3 2023 Nov 15, 2023	SELL	$211.82 - $248.24 $190,638 - $223,416	-900 Reduced 40.91%	1,300 $293,000
Q2 2023 Aug 23, 2023	BUY	$205.19 - $232.99 $451,418 - $512,578	2,200 New	2,200 $485,000
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $569,240 - $683,676	2,800 New	2,800 $582,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $1.11 Million - $1.43 Million	-6,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $36,864 - $43,216	200 Added 3.08%	6,700 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $3.47 Million - $4.15 Million	-19,300 Reduced 74.81%	6,500 $1.21 Million
Q2 2021 Aug 06, 2021	BUY	$170.47 - $211.93 $3.26 Million - $4.05 Million	19,100 Added 285.07%	25,800 $4.57 Million
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $431,032 - $489,580	2,800 Added 71.79%	6,700 $1.11 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $601,033 - $895,561	-5,900 Reduced 60.2%	3,900 $580,000
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $139,860 - $169,582	-1,400 Reduced 12.5%	9,800 $990,000
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $129,836 - $176,148	-1,400 Reduced 11.11%	11,200 $1.34 Million
Q1 2020 May 11, 2020	BUY	$79.39 - $115.35 $1 Million - $1.45 Million	12,600 New	12,600 $1.22 Million
Q4 2019 Feb 12, 2020	SELL	$78.31 - $95.34 $2.51 Million - $3.06 Million	-32,100 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $52,394 - $60,193	-700 Reduced 2.13%	32,100 $2.6 Million
Q2 2019 Aug 20, 2019	BUY	$76.06 - $120.81 $555,238 - $881,913	7,300 Added 28.63%	32,800 $2.56 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $2.73 Million - $3.23 Million	25,500 New	25,500 $2.99 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $1.52 Million - $1.93 Million	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $1.09 Million - $1.24 Million	-9,600 Reduced 39.02%	15,000 $1.92 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $396,677 - $562,178	-3,700 Reduced 13.07%	24,600 $2.76 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $3.64 Million - $4.64 Million	-30,700 Reduced 52.03%	28,300 $4.19 Million
Q3 2017 Nov 15, 2017	BUY	$114.6 - $136.81 $6.76 Million - $8.07 Million	59,000	59,000 $6.91 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$1.97 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.59 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.14 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.03 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$808 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account